Results 251 to 260 of about 121,021 (313)

3D‐Printed Cut Guides and Custom Prostheses for Pelvic Reconstruction in Bone Sarcoma Patients: Complications, Survival Rates, and Functional Outcomes

Orthopaedic Surgery, Volume 18, Issue 2, Page 311-321, February 2026.
A 60‐year‐old male patient with Grade 2 chondrosarcoma. High‐intensity signals were observed in the coronal (A) and transverse (B) MRI images (T1‐fat suppression with contrast) in the left hemi‐pelvis, involving the periacetabular area but without infiltration into the hip joint.
Luca Cevolani, Benedetta Spazzoli, Eric Lodewijk Staals, Costantino Errani, Laura Campanacci, Paolo Spinnato, Massimiliano De Paolis, Giuseppe Bianchi, Davide Maria Donati   +8 more
wiley   +1 more source

Enhancing prognostic precision: exploring the role of lung immune prognostic index in immunotherapy-treated soft tissue sarcoma patients-a retrospective study. [PDF]

J Orthop Surg Res
Sun M, Kang H, Luo Y, Zhou Y, Wang Y, Tang F, Lu M, Min L.   +7 more
europepmc   +1 more source

Extraarticular Knee Joint Resection: Indications, Results, and Complications in a Series of 30 Patients

Orthopaedic Surgery, Volume 18, Issue 2, Page 335-346, February 2026.
Extraarticular Knee Joint Resection is oncologically effective but carries significant functional and complication considerations. The patellar coronal osteotomy sparing the extensor mechanism (Type‐B resection) balances oncological safety and functional preservation, especially for benign aggressive tumors.
Carmine Zoccali, Giuseppe Francesco Papalia, Giovanni Cepparulo, Jacopo Baldi, Francesca Sperati, Andrea Amendola, Nicola Salducca, Stefano Gumina   +7 more
wiley   +1 more source

The use of pegylated liposomal doxorubicin in metastatic soft tissue sarcoma. [PDF]

Acta Oncol
Pham T, Krogh Rose H, Rossen P, Aggerholm Pedersen N.   +3 more
europepmc   +1 more source

Therapeutic targeting of chromatin alterations in leukemia and solid tumors

International Journal of Cancer, Volume 158, Issue 2, Page 382-408, 15 January 2026.
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner, Tobias Berg, Daniel Sasca, Sophie‐Luise Mersiowsky, Jayant Y. Gadrey, Johanna Thomas, Michael W. M. Kühn, Michael Lübbert   +7 more
wiley   +1 more source

Novel Therapeutics in Soft Tissue Sarcoma. [PDF]

Cancers (Basel)
Mavroeidis L, Napolitano A, Huang P, Jones RL.   +3 more
europepmc   +1 more source

Clinico-Pathological and Clinical Outcomes of Soft Tissue Sarcoma With FUS-TFCP2 or EWSR1-TFCP2 Fusions: A Case Series From North India. [PDF]

Cureus
Agarwal K, Rastogi S, Pasricha S, Dharmashaktu Y, Aggarwal A.   +4 more
europepmc   +1 more source

Blood-based biomarkers in soft tissue sarcoma: Implications for immune checkpoint inhibitor therapy. [PDF]

Int J Cancer
Mannah BA, Park JJ, Lim SY.
europepmc   +1 more source

Efficacy and safety of vascular-targeting agents in advanced soft tissue sarcoma: a systematic review and network meta-analysis. [PDF]

Ther Adv Med Oncol
Wang Y, Xu H, Sa Q, Zhou Y, Cheng H, Gao R, Xu B, Wang J.   +7 more
europepmc   +1 more source

Detailed Analysis of Prognostic Factors in Patients with Soft Tissue Sarcoma Undergoing Unplanned Excision. [PDF]

Med Princ Pract
Tsuchie H, Emori M, Murata S, Murahashi Y, Mizushima E, Shimizu J, Nagasawa H, Teramoto A, Miyakoshi N.   +8 more
europepmc   +1 more source